FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I) (I), including pharmaceutically acceptable salts of the compound. In formula (I): M is selected from the group consisting of iron, ruthenium and osmium, X is selected from the group consisting of Cl-, Pf6-, Br-, Bf4-, ClO4-, CF3SO3- and SO4-2, n=0, 1, 2, 3, 4 or 5, y=1, 2 or 3, z=0, 1 or 2, Lig in each occurrence is independently selected from the group consisting of R1 is selected from the group consisting of
and u is an integer, each of R2a, R2b, R2c, R2d, R2e and R2f is hydrogen, R3a, R3b, R3c, R3d, R3e, R3f, R3g, R3h and R3i in each occurrence, each is independently selected from the group consisting of hydrogen and C1-6 alkyl, R4a R4b and R4c in each occurrence is hydrogen; or R4a and R4b in each occurrence, when they are present on a thiophene ring together with the atom to which they are bound to form an optionally substituted ring having 6 ring atoms containing two oxygen atoms. Number of compounds specified in the claims is excluded. Method for treating, method for destroying pathogens, method for sterilizing and method for using a compound of formula (I) as a diagnostic agent are also provided.
EFFECT: compounds according to the invention can be used as agents for diagnosing, treating or preventing diseases associated with unwanted and/or hyperproliferative cell etiology, including cancer and diseases associated with unwanted and/or hyperproliferative cells.
12 cl, 17 tbl, 47 dwg
Title | Year | Author | Number |
---|---|---|---|
METAL-BASED COORDINATION COMPLEXES AS PHOTODYNAMIC COMPOUNDS AND USE THEREOF | 2014 |
|
RU2682674C2 |
METAL-GLYCOPROTEIN COMPLEXES AND USE THEREOF AS CHEMOTHERAPEUTIC COMPOUNDS | 2016 |
|
RU2742981C2 |
OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2734261C2 |
OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2815636C1 |
OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2719422C2 |
19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2014 |
|
RU2675855C2 |
COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
HEMIASTERLYN DERIVATIVES AND APPLICATION THEREOF FOR AT CANCER TREATMENT | 2003 |
|
RU2342399C2 |
COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING IT, POSSESSING ANALGESIC ACTIVITY | 2011 |
|
RU2565073C2 |
Authors
Dates
2019-01-22—Published
2013-04-15—Filed